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Equine albumin solution can be a good therapeutic option in ﬂuid replacement for
treatment of horses with colic. The purpose of this study was to evaluate the effects of
initial ﬂuid therapy with equine albumin solution in horses presenting with colic and
mild-to-moderate dehydration, and to compare this therapy with ﬂuid therapy based
on crystalloids alone. Nineteen horses of both genders presenting with colic and mild-
to-moderate dehydration were used. Animals were randomly assigned to one of two
groups (control: ﬂuid therapy based on crystalloid solutions; experimental: ﬂuid
therapy based on equine albumin and crystalloid solutions). Physical examination,
hematocrit determination, blood gas analysis, serum biochemistry, blood and perito-
neal lactate assessment, and measurement of colloid osmotic and arterial pressure
were performed at predetermined times. Good results were obtained with equine
albumin solution. More ﬂuid is attracted into and maintained in the intravascular
compartment, despite infusion of small volumes, as indicated by higher arterial pres-
sure, lower capillary reﬁll time, lower hematocrit and serum protein concentrations,
lower colloid osmotic pressure, and better skin turgor. Equine albumin solution has
good oncotic action and is a safe ﬂuid therapy option for horses with colic and mild-to-
moderate dehydration. Our results suggest it can be a good choice of ﬂuid for
correction of severe dehydration, although further research is necessary to determine
the adequate dose in such cases.
 2013 Elsevier Inc. All rights reserved.1. Introduction
Albumin is present in 5% or 25% solutions at 96% purity
and can be used as a colloidal agent in humans [1].
In horses, crystalloids are used more often than colloids
even in cases of severe hypovolemia because of their lower
price and lower risk of side effects [2]. However, ﬂuid
replacement with crystalloids alone may not be enough to
re-establish adequate circulation in cases of acutePhD, Departamento
a e Zootecnia, Uni-
arques de Paiva 87,
aulo, Brazil.
ll rights reserved.circulatory failure or severe dehydration (often seen in
horses with colic), where hypertonic saline or colloid
solutions may be indicated more [3,4].
To date, species-speciﬁc plasma is the most commonly
used colloid in horses, despite its decreased ability to
increase oncotic pressure owing to rapid redistribution of
proteins into the extravascular space [5]. Synthetic colloids
have only transient effects on plasma volume and are
devoid of other functions, such as the transport of
substances [1].
The use of albumin as a colloid in horses could have
many advantages. The primary action of albumin is main-
tenance of oncotic pressure, but it also helps transport
many substances, ligates reversibly with cations and
anions, and is a free radical scavenger [6].
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found in the literature and most involve the use of human
albumin. Several experimental studies were performed
with good results in laboratory animals [7], dogs [8], sheep
[9], and guinea pigs [10].
Reports and studies on clinical cases refer to the use of
human albumin in small animals and horses, given that
albumin obtained from other species is not commercially
available [6,11]. Trow et al. [12] reported good results,
with increase in serum albumin concentration and
oncotic pressure, after the use of 10% albumin in 73 dogs
suffering from different conditions. Viganó et al. [13] re-
ported good safety after the use of 5% human albumin in
small animals presenting with hypoalbuminemia. Both
studies reported frequent occurrence of low-grade side
effects.
There is only one previous study that evaluated the
behavior of homologous albumin in horses [14]. In that
experiment, ﬂuid therapy with concentrated equine
albumin (5% in normal saline) was compared with ﬂuid
therapy with normal saline solution alone for treatment of
induced mild-to-moderate dehydration. The authors
concluded that the albumin solution is easy to prepare and
to infuse and has no adverse effects and that a small volume
of the solution has similar effects to infusion under pres-
sure of half the calculated volume of saline solution for
hydration of the same animal.
Equine albumin solution may be a good option for
treatment of horses with colic, particularly in shock situa-
tions; in cases where hypoproteinemia is a concern; and for
raising arterial pressure in patients who require surgical
intervention. However, the correct dose and speed of
administration must be established in healthy animals
before the ﬂuid can be used in clinical situations.
The purpose of this study was to evaluate the effects of
equine albumin solution in initial ﬂuid therapy in horses
presenting with colic and mild-to-moderate dehydration
and to compare it with ﬂuid therapy based on crystalloids
alone.
2. Materials and Methods
2.1. Animals
Nineteen horses of both genders presenting with colic
due to different causes and with mild-to-moderate dehy-
dration to the Veterinary Hospital of the Faculdade de
Medicina Veterinária e Zootecnia da Universidade de São
Paulo were selected.
Animals were randomly assigned to one of two groups
(CG [control]: ﬂuid therapy based on crystalloid solutions;
EG [experimental]: ﬂuid therapy based on equine albumin
and crystalloid solutions).
2.2. Initial Assessment
Initial assessment of all animals was performed
according to the standard protocol adopted at the Veteri-
nary Hospital and included signalment; weighing; anam-
nesis; general physical assessment; abdominal, cardiac, and
pulmonary auscultation; nasogastric tubing; abdomi-
nocentesis; rectal palpation; andhematocrit determination.Arterial blood was sampled for blood gas analysis; total
blood without anticoagulant was sampled for determina-
tion of total serum protein, albumin, urea, creatinine,
aspartate aminotransferase (AST), g-glutamyl transferase
(GGT), and bilirubin; and total blood with anticoagulant
was sampled for complete blood cell count. Colloid osmotic
pressure and blood and peritoneal lactate were assessed.
Arterial pressure was measured at the coccygeal artery
using a sphygmomanometer and Doppler ultrasonography.
Biochemical workup was performed to assess the initial
state of the patient (severity of the colic) and the changes
during and/or after ﬂuid therapy in both groups (CG and
EG).
The hematocrit was determined using a microcapillary
tube and a centrifuge. Blood gas variables were quantiﬁed
using an automatic pH and blood gas analyser (OMNI
Modular System, AVL, Roche Diagnostics, Graz, Austria).
Serum total protein, albumin, AST, GGT, bilirubin, urea, and
creatinine were quantiﬁed using an automatic biochemical
analyser (Lyasis, AMS Diagnostics, Summerville, South
Carolina, EUA). Lactate was measured with a portable lac-
tometer (Accutrend, Roche, Mannhein, Germany). Colloid
osmotic pressure was quantiﬁed using a colloid osmometer
(model 4420, Wescor, Utah, USA).
2.3. Fluid Therapy Calculation and Administration
The level of dehydration was estimated based on skin
turgor, hematocrit, and capillary reﬁll time (CRT), according
to the table given by Seahorn and Cornick-Seahorn [15].
The volume of ﬂuid to be replaced was calculated as body
weight multiplied by the estimated percentage of
dehydration.
After estimation of the percentage of dehydration and
calculation of the volume of ﬂuid to be replaced, intrave-
nous ﬂuid therapywas started, based on the group involved
(CG or EG), as follows: continuous infusion of crystalloid
solution alone (CG), and continuous infusion of albumin
solution followed by crystalloid solution (EG).
The crystalloid of choice was lactated Ringer’s solution.
The albumin used in the EG was manufactured [16] and
provided by Instituto Butantan (Brazilian government-
owned research center) in lyophilized form in 35-mL
vials. This product was used for preparation of the 5%
solution (in normal saline) administered to the patients.
The ﬁnal dose per animal was 8 mL/kg body weight, based
on the mean volume used in a previous experiment with
the same solution [14].
2.4. Assessment During Fluid Therapy
During ﬂuid therapy, heart and respiratory rates,
mucousmembrane color, CRT, skin turgor, arterial pressure,
blood gas analysis, hematocrit, serum total protein, and
albumin concentrations were reassessed.
Reassessments were performed after administration of
the albumin solution (EG) and at 30, 60, and 120 minutes
after crystalloid solution administration was started (EG
and CG).Whenever the calculated volume of ﬂuid could not
be given within this interval, an additional reassessment
was performed at the end of the ﬂuid therapy. Reassess-
ment times (T) were sequentially numbered throughout
Table 1
Correspondence between experimental times in each group
Experimental Times Control Group (CG) Experimental Group (EG)
T0 Before ﬂuid therapy Before ﬂuid therapy
T1 30 minutes after administration of crystalloids was started After administration of albumin solution
T2 60 minutes after administration of crystalloids was started 30 minutes after administration of crystalloids was started
T3 120 minutes after administration of crystalloids was started
or end of ﬂuid therapy
60 minutes after administration of crystalloids was started
T4 End of ﬂuid therapy 120 minutes after administration of crystalloids was started
or end of ﬂuid therapy
T5 - End of ﬂuid therapy
Table 2
Mean and standard deviation of systolic arterial pressure (mm Hg) of
animals in the control (CG) and experimental (EG) groups at different
times
Group T0 T1 T2 T3 P
CG 13.70  2.57 14.35  2.35 14.55  2.24 13.43  1.05 .7546
EG 12.38  3.18 13.05  2.43 13.94  1.92 14.06  2.06 .4490
P .3348 .2551 .5385 .4573
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peritoneal lactate were also reassessed after ﬂuid therapy.
Data were statistically compared before and after ﬂuid
therapy and between the two groups. Statistical analysis
was performed using GraphPad InStat (version 3.01, 1998,
GraphPad Software, San Diego, CA, USA).
This project was approved by the Bioethics Committee
of the Faculdade de Medicina Veterinária e Zootecnia da
Universidade de São Paulo (protocol 933/2006).
3. Results and Discussion
Horses of different pure breeds (Mangalarga, Stan-
dardbred, Appaloosa, Brazilian Sport Horse, and Quarter
Horse) and of mixed breeds were included in the study.
There were 14 male (seven in each group) and ﬁve female
(three in the CG and two in the EG) horses. The causes of
colic included three cases of nephrosplenic entrapment,
three cases of large-colon impaction, two cases of enter-
oliths, two cases of large-colon displacement, and one case
each of epiploic foramen entrapment, inguinal ring
entrapment, small-colon impaction, foreign body in the
small colon, cecocolic intussusception, cecal distention,
anterior enteritis, gastric overload with gastritis, and
postovulation hemoperitoneum.
Mean age of the patients was 11.60 7.05 years (ranging
from 3 to 22 years) in the CG and 9.33  6.20 (ranging from
2 to 19 years) in the EG, with no statistical difference
between groups (P ¼ .4696). Mean body weight was 445.0
 70.2 kg in the CG and 424.1  61.9 kg in the EG, with no
statistical difference between groups (P ¼ .5035).
Complete blood cell count, AST, GGT, bilirubin, and
ﬁbrinogen determinations were performed only at the
beginning of the clinical evaluation as part of a standard
protocol for colic cases and to rule out other concurrent
conditions that might interfere with the results of this
study. Two animals (animal 2 in the CG and animal 8 in the
EG) had prerenal azotemia that was not totally reversed
after the proposed ﬂuid therapy but resolved without
further complications as treatment progressed.
Mean dehydrationwas 4.9%  0.9% in the CG and 5.1% 
1.1% in the EG, with no statistical difference between
groups (P ¼ .6756).
Some data could not be obtained from all patients at all
times, as the need for urgent surgical intervention
precluded complete hydration in some cases. In other cases,
animals were too restless to allow collection of all samples
and data. However, this did not compromise the experi-
ment, given that themost important results liewithin times0 and 1 hour, when all variables could be obtained. Also, the
idea behind this project was to work with clinical cases to
evaluate the feasibility of the proposed procedures and
treatments, and thus our ﬁnal results are directly applicable
to clinical situations.
There are no reports of adverse side effects of plasma
transfusion in horses in the literature [17], although other
authors have observed such reactions in foals only [18].
In humans, some complications are reported with
albumin solution, including transfusion-like reactions,
hypocalcemia, decreased initial urine output, and
pulmonary edema [19]. Allergic reactions are rare, and the
risk of pulmonary dysfunction seems to be more related
with the original condition than with the type of ﬂuid
used [1]. Moreover, despite ongoing controversy, there are
studies showing that albumin is safer than synthetic
colloids in humans [20]. Side effects related to the use of
human albumin have been reported in small animals;
however, these side effects tended to be of less signiﬁ-
cance [12,13].
As in previous studies [14], our results suggest that the
use of albumin solution is safe, given that no side effects
were observed. This may be because of the level of purity of
the product used and the fact that it was species speciﬁc.
When human albumin is used in other species, the risk of
immediate or late adverse reaction is higher [6].
The lyophilized preparation was evaluated. This prepa-
ration is more practical for storage and is not prone to
contamination, as is the case with the fresh refrigerated
bags used in a previous study [14], although the small
volume contained in each vial increases the time required
for preparation of the ﬁnal solution. Given the goal is to use
the product in patients suffering from severe dehydration
or shock, which might require larger volumes than those
used here, the time required for preparation of the solution
is a possible downside of this preparation.
During ﬂuid therapy, heart and respiratory rates, body
temperature, and cecal movements varied more according
to the original condition than to the hydration. Body
temperature tended to drop during ﬂuid therapy, possibly
Fig. 1. Systolic arterial pressure (mm Hg) of animals in the control (CG) and
experimental (EG) groups at different times.
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This was statistically signiﬁcant in the EG between T0
(37.77  0.37) and T1 (37.24  0.56) (P ¼ .0207) but did not
differ between groups. The statistical difference observed
in the EG may reﬂect the inﬂuence of room temperature or
the small number of subjects studied. There is no reason
why albumin should cause a decrease in body temperature
in animals, and in humans, the expected reaction would be
one of hyperthermia.
Mucous membrane color tended to improve with ﬂuid
therapy in both groups, with no statistical difference
between groups. The variations of this variable weremostly
related to the original condition.
Blood gas variables were generally within normal limits
in both groups at all times. The few changes observed,
mostly in bicarbonate and base excess values, seemed to be
more related to the original condition than to ﬂuid therapy.
Respiratory changes, listed in the literature as one of the
possible complications related to the use of albumin in
humans, were not observed in this or in a previous study
[14]. Respiratory rates actually decreased more in the EG,
with signiﬁcant (P ¼ .0378) differences between T1 (17.7 
6.3) and T2 (29.3 13.2) andwith no signiﬁcant differences
between groups. Should albumin cause respiratory changes
related to pulmonary edema, an increase in respiratory
rates would be expected and not otherwise.
Serum urea and creatinine values did not differ signiﬁ-
cantly before and after ﬂuid therapy or between groups,
although values tended to drop in most patients, possibly
reﬂecting the correction of prerenal azotemia, as expected
after ﬂuid therapy.
Blood and peritoneal lactate values did not vary signif-
icantly between times or groups. This variable, particularly
peritoneal lactate, has a good correlation with the prog-
nosis in cases of colic [21] but is not strongly correlated
with the responses to initial treatment.Table 3
Mean and standard deviation of the hematocrit (%) of animals in the control (CG
Group T0 T1
CG 42.30  5.77a 35.10  5.68b
EG 39.11  6.47a 33.55  5.12b
P .2719 .5441
Different letters in the same row indicate signiﬁcant difference.
* Signiﬁcant difference.Arterial pressure (systolic, diastolic, and mean values)
tended to increase during ﬂuid therapy, particularly in
patients presenting with lower arterial pressure. In the
remaining patients, arterial pressure remained stable or
decreased slightly when values were initially high due to
pain. Systolic arterial pressure values (mean and standard
deviation) are given in Table 2 and Figure 1.
A similar pattern of nonsigniﬁcant increase in arterial
pressure due to great individual variation was reported in
other studies [14,22]. It should be noted that the increase in
arterial pressure in the EG (T1) was due to the oncotic
action of albumin solution, given that the volume infused
was not large enough to cause such an increase. A long-
lasting hemodynamic improvement of up to 36 hours
after albumin infusion is also observed in humans [23].
CRTs decreased with ﬂuid therapy in both groups.
Differences between T1 (2.20  0.42 seconds) and T0
(2.40  0.51 seconds) were nonsigniﬁcant in the CG
(P¼ .3434) and signiﬁcant in the EG (T0¼ 2.55 0.52; T1¼
2.00  0.50; P ¼ .0133). In T1, the fact that horses in the EG
received albumin solution only (3.0-4.5 L, depending on
body weight) and those in the CG received a larger amount
of ﬂuid (almost twice as much in some cases) suggests that
the colloidal action of albumin led to greater ﬂuid retention
in the intravascular compartment.
The same rationale can be extrapolated to interpret skin
turgor responses. Values decreased signiﬁcantly (P¼ .0150)
between T0 (2.50  0.70) and T1 (2.00  0.94) in the CG,
with no signiﬁcant differences in the EG (T0 ¼ 2.44  0.88;
T1 ¼ 2.33  0.70; P ¼ .3466), suggesting a rapid ﬂuid shift
from the intravascular to the interstitial space. After ﬂuid
therapy, the hematocrit decreased signiﬁcantly in both
groups (Table 3), as expected. Differences were signiﬁcant
between T0 and T1 and between T0 and time of last data
collection but not between groups, again suggesting
a useful osmotic action of the equine albumin solution.
Serum total protein followed a similar pattern,
decreasing signiﬁcantly with ﬂuid therapy between T0 and
T1 in both groups (CG: P ¼ .0001; EG: P ¼ .0003), with no
signiﬁcant differences between groups. Albumin also
decreased signiﬁcantly with ﬂuid therapy between T0 and
T1 in both groups (CG: P ¼ .0337; EG: P ¼ .0018), with no
signiﬁcant differences between groups. Although the EG
was given exogenous albumin, the colloidal action was
greater than the increase observed in albumin serum
dosage. A large increase in serum albumin concentration
was not expected because the volume infused was small
and because a greater intravascular ﬂuid retention to the
detriment of serum albumin concentration has been
described [14] in horses with induced mild-to-moderate
dehydration, even though serum albumin concentrations
tended to be higher in the EG than in the CG in this study.) and experimental (EG) groups at different times
T2 T3 P
34.70  4.71bc 32.50  4.84d .0019*
32.25  5.33b 32.37  5.04b .0465*
.4434 .9604
Table 4
Mean values and standard deviation of colloid osmotic pressure (mm Hg) of animals in the control (CG) and experimental (EG) groups
Group T0 T1 T2 T3 T4 P
CG 26.98  5.2a 23.15  3.5b 22.1  3.4c 21.36  3.2d 21.5  3.9 .0217*
EG 26.03  3.7a 22.41  3.7b 20.76  4.14c 18.78  2.7c 17.92  2.5 .0022*
P .6584 .6642 .4674 .1130 .1781
T4 was not included in the statistical analysis owing to the low number of samples obtained.
Different letters in the same row indicate statistically signiﬁcant difference.
* Signiﬁcant difference.
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readings obtained by means of a colloid osmometer are
displayed in Table 4. T4 was not included in the statistical
analysis because of the small number of samples obtained.
Direct readings of colloid osmotic pressure are much more
precise than its estimation using mathematical equations.
Fluid therapy led to a decrease in colloid osmotic pressure
in both groups. This was expected, given that the ﬂuid used
in large volumes was a crystalloid (lactated Ringer’s solu-
tion), which has a lower oncotic pressure than blood.
Colloid osmotic pressure in T0 and T1 did not differ
signiﬁcantly between groups but differed signiﬁcantly
within each group. The lack of difference in T1 between
groups reﬂects the colloidal action of albumin, given that
the small volume of crystalloid used in the preparation of
the albumin solution could not have accounted for such
changes in colloid osmotic pressure.
Human albumin led to an increase in serum albumin
concentration and oncotic pressure in dogs [12]. This was
not observed in this study. However, in the study in dogs,
larger amounts were infused and oncotic pressure was not
assessed right after infusion, as in this study, where the
purpose was to demonstrate the effects of plasma expan-
sion and where animals did not have hypoalbuminemia.
Colloid osmotic assessment was a good method to
demonstrate the shift of ﬂuid to the intravascular space.
Despite the lack of signiﬁcant differences between groups
at the end of the ﬂuid therapy, values tended to be lower in
the EG (Fig. 2). It should be noted that ﬂuid therapy was
generallymore prolonged in the EG than in the CG owing to
the inclusion of an additional step (albumin delivery) in the
procedure in that group. A greater ﬂuid redistribution and
smaller ﬂuid retention could thus be expected but was not
observed.Fig. 2. Colloid osmotic pressure (mm Hg) of animals in the control (CG) and
experimental (EG) groups at different times.Equine albumin had a good oncotic action, increasing
the ﬂuid shift to the intravascular space, despite the small
volumes infused, as suggested by the increase in arterial
pressure, lower CRT, lower hematocrit and serum total
protein, reduced colloid osmotic pressure, and mainte-
nance of skin turgor.
Despite the good results obtained with equine albumin
solution in horses in this study, further research is needed
to determine the dose required for treatment of emergen-
cies involving severe dehydration/shock, and this cannot be
extrapolated from this study.
4. Conclusions
Equine albumin solution is a safe colloid for use in
horses suffering from colic with mild-to-moderate dehy-
dration. It might be a good choice of colloid for treatment of
severe dehydration, but further studies are necessary to
determine the best dose in such cases.
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